News Daily News ‘Gaming’ the AUC for Revascularization? Study Suggests Not Michael O'Riordan March 25, 2021
News Daily News Primary PCI Underused but Just as Effective in Cancer Patients With STEMI Michael O'Riordan February 04, 2021
News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021
News Daily News Microvascular Thrombi Common in Patients Dying of COVID-19 Michael O'Riordan January 27, 2021
News Daily News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Michael O'Riordan January 12, 2021
News Daily News Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests Michael O'Riordan January 05, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition Michael O'Riordan December 11, 2020
News Daily News Type 2 MI Patients Often Miss Out on Seeing a Cardiologist Caitlin E. Cox November 23, 2020
News Conference News AHA 2020 OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP Shelley Wood November 14, 2020
News Conference News AHA 2020 Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS Michael O'Riordan November 14, 2020
News Daily News More Circulating Omega-3s May Boost Prognosis After STEMI Todd Neale October 26, 2020
News Conference News TCT 2020 Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care Michael O'Riordan October 19, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Conference News ESC 2020 Trimetazidine Safe but Not Protective Long-term After PCI Caitlin E. Cox August 30, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020
News Daily News More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California Shelley Wood May 22, 2020
News Daily News Alirocumab ‘Modestly’ Cost-effective at Lower List Price: ODYSSEY OUTCOMES Michael O'Riordan May 04, 2020
News Features Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms Caitlin E. Cox April 23, 2020
News Conference News ACC 2020 Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA Shelley Wood March 29, 2020